Literature DB >> 21622153

Identification of protein-protein interactions of human HtrA1.

Mara Campioni1, Anna Severino, Lucrezia Manente, Antonio De Luca, Raffaele La Porta, Antonio Vitiello, Paola Fiore, Stefano Toldo, Enrico P Spugnini, Marco G Paggi, Alfonso Baldi.   

Abstract

The human heat shock protein HtrA1, a member of the HtrA family of serine proteases, is a evolutionarily highly conserved factor which displays a widespread pattern of expression. The yeast two-hybrid technique was employed to identify new cellular proteins physically interacting with HtrA1, and thus potential targets of this serine protease. An enzymatically inactive HtrA1 point mutant, HtrA1-S328A, was generated and used as bait in a yeast two-hybrid system. Fifty-two plasmids were isolated from primary positive yeast clones. Subsequent sequencing and BLAST analysis revealed cDNAs encoding for 13 different proteins. These putative binding partners of HtrA1 appeared to be a) components of extracellular matrix; b) factors related to signal pathways, and c) unknown proteins. Among the 13 positive clones identified and reported here, it is worth of note that the interaction of HtrA1 with tubulin and collagen (extracellular matrix proteins) and with tuberin (cytoplasmic protein) is confirmed by other studies, and this further supports previous findings in which HtrA1 can be found active as an intracytoplasmic protein or as secreted protein as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622153     DOI: 10.2741/e350

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  4 in total

1.  The autolysis of human HtrA1 is governed by the redox state of its N-terminal domain.

Authors:  Michael W Risør; Ebbe Toftgaard Poulsen; Line R Thomsen; Thomas F Dyrlund; Tania A Nielsen; Niels Chr Nielsen; Kristian W Sanggaard; Jan J Enghild
Journal:  Biochemistry       Date:  2014-06-06       Impact factor: 3.162

Review 2.  The advantages of drug treatment with statins in patients with SARS-CoV-2 infection.

Authors:  Francesco Ferrara; Antonio Vitiello
Journal:  Wien Klin Wochenschr       Date:  2021-03-29       Impact factor: 1.704

3.  Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer.

Authors:  Anna Lehner; Viktor Magdolen; Tibor Schuster; Matthias Kotzsch; Marion Kiechle; Alfons Meindl; Fred C G J Sweep; Paul N Span; Eva Gross
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

4.  Epigenetic silencing of serine protease HTRA1 drives polyploidy.

Authors:  Nina Schmidt; Inga Irle; Kamilla Ripkens; Vanda Lux; Jasmin Nelles; Christian Johannes; Lee Parry; Kirsty Greenow; Sarah Amir; Mara Campioni; Alfonso Baldi; Chio Oka; Masashi Kawaichi; Alan R Clarke; Michael Ehrmann
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.